Policy & Regulation
AstraZeneca acquires biotechnology company Omniose to strengthen vaccine capabilities
10 November 2026 - Preclinical biotechnology company Omniose announced on Tuesday that it has been acquired by biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN).This acquisition...
Medivir secures US patent protection for fostrox and lenvatinib combination until 2044
10 November 2026 - Swedish pharmaceutical company Medivir AB (STO:MVIR) announced on Tuesday that it has secured a US patent covering the combination of fostroxacitabine bralpamide (fostrox) and lenva...
PharmaLogic to acquire CDMO business and manufacturing facility from Lantheus
10 November 2026 - PharmaLogic Holdings Corp, an independent contract development and manufacturing organisation (CDMO) specialising in radiopharmaceuticals, announced on Monday a definitive agreement...
Ribo submits European Clinical Trial Application for SR122 in mixed and severe dyslipidaemia
10 November 2026 - China-based biopharmaceutical company Suzhou Ribo Life Science Co Ltd (HK:06938) and its Swedish subsidiary Ribocure Pharmaceuticals AB (collectively referred to as Ribo) announced ...
Cordex enters exclusive licensing and supply agreements with Avanzanite Bioscience for Zemcelpro (dorocubicel)
10 November 2026 - Blood stem cell therapies company ExCellThera Inc, the parent company of Cordex Biologics, announced on Monday that Cordex has entered into exclusive licensing and supply agreements...
Spermosens and Genea agree IVF study of JUNO-Checked in Australia
9 November 2026 - Swedish fertility diagnostics company Spermosens AB (Spotlight Stock Market: SPERM) said on Monday it has signed a collaboration framework agreement with Australian fertility group G...